Filing Details
- Accession Number:
- 0001104659-20-139783
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-28 16:30:50
- Reporting Period:
- 2020-12-28
- Accepted Time:
- 2020-12-28 16:30:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1279704 | Cellectar Biosciences Inc. | CLRB | Pharmaceutical Preparations (2834) | 043321804 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1326487 | Dov Elefant | C/O Cellectar Biosciences, Inc. 100 Campus Drive Florham NJ 07932 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-28 | 7,407 | $1.35 | 11,755 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
